TBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TrueBlue Inc (TBI) is not a strong buy for a beginner investor with a long-term strategy at this time. While there are positive catalysts like insider buying and improving financials, the stock's overbought technical indicators, lack of significant trading signals, and mixed analyst sentiment suggest waiting for a better entry point.
The MACD is positive and contracting, indicating a bullish trend, but the RSI at 81.871 signals the stock is overbought. The stock is trading near resistance levels (R1: 4.578, R2: 4.927), suggesting limited immediate upside potential.
Insiders are buying significantly, with a 1035.89% increase in buying activity over the last month. Financials show YoY revenue growth of 8.35% and significant improvement in net income and EPS.
The stock is overbought based on RSI. Gross margin has dropped by 19.79% YoY. Analyst price target was lowered recently from $7 to $5.50, indicating reduced confidence.
In Q4 2025, revenue increased by 8.35% YoY to $418.18M. Net income improved significantly to -$31.54M (up 169.42% YoY), and EPS increased by 162.50% YoY to -1.05. However, gross margin declined by 19.79% YoY to 20.06%.
Baird recently lowered the price target from $7 to $5.50 but maintained an Outperform rating. This indicates cautious optimism but reduced confidence in near-term upside.
